Treatment of aortic disease with innovative technologies
Terumo Aortic, a new brand formed from two leading companies in the treatment of aortic disease: Bolton Medical of the United States and Vascutek of the United Kingdom, as part of the Japan-based global healthcare company Terumo.
With a focus on the treatment of thoracic and abdominal aortic disease using surgical and stent grafts, Terumo Aortic provides a comprehensive portfolio tailored to meet the needs of surgeons, contributing to the treatment of over 2 million patients in excess of 90 countries globally.
Xổ số kiến thiết tuần thơAortic aneurysm and dissection can lead to a life-threatening rupture and malperfusion of the aorta; suitable treatment with a surgical graft or implantation of a stent graft can help save a patient's life. There is also a hybrid treatment option which is a combination of surgical and endovascular procedures.
Xổ số kiến thiết tuần thơNote: The regulatory approval status and availability of these products differ by country or region.
Thoracic vascular graft
Abdominal vascular graft
Thoracic stent graft
Abdominal stent graft
Xổ số kiến thiết tuần thơAbdominal stent graft